Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine for Hoarding Disorder
NCT04035850Phase 3Withdrawn
- Start
- Aug 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vortioxetine in hoarding disorder (HD). Planned start Aug 2019; status: withdrawn.
02
Drugs
vortioxetine
03
Conditions
hoarding disorder (HD)
Beyond the preview
Go deeper on NCT04035850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04035850.